A potentially more heart-friendly sequential chemotherapy regimen for breast cancer proved as effective as the standard concurrent approach but with less cardiotoxicity. Med Page Today, 11/16/2013. (Also see: Cancer and Scleroderma)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.